Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 10NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Head and Neck Neoplasms 12Squamous Cell Carcinoma of Head and Neck 10Colorectal Neoplasms 10Rectal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 5Esophageal Neoplasms 4Colonic Neoplasms 4Adenocarcinoma of Lung 4Uterine Cervical Neoplasms 3Adenocarcinoma Of Esophagus 3Tongue Neoplasms 2Precancerous Conditions 2Papillomavirus Infections 2Pancreatic Neoplasms 2Esophageal Squamous Cell Carcinoma 2Anus Neoplasms 2Anal Canal Carcinoma 2Adenocarcinoma, Bronchiolo-Alveolar 2Radiation Injuries 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Hereditary Sensory and Autonomic Neuropathies 1Colorectal Cancer Metastatic 1Carcinoma, Ovarian Epithelial 1

Interventions

tremelimumab 1durvalumab 1Leucovorin 1Fluorouracil 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Colorectal Cancer Metastatic × Cetuximab × Clear all
NCT01522612 2016-06-10

Colorectal Cancer (CRC) Cetuximab Elderly Frail

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
5 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡